Abstract
BACKGROUND Cancer is a rising cause of morbidity and mortality in low- and middle-income countries (LMICs). Individuals diagnosed with cancer in LMICs often have limited access to cancer prevention, diagnosis, and treatment services. Social support after a cancer diagnosis is associated with positive health outcomes in the long term. Digital technologies, such as the Internet and mobile phones, could be used to provide support to individuals with cancer in a more accessible way. This scoping review aims to understand how digital technology is currently being utilized by individuals with cancer for social support in LMICs.
METHODS Four electronic databases were searched up to June 2024 to identify studies that reported on the use of digital technology for cancer social support in LMICs. Articles were included if they were published in English, included adults diagnosed with any type of cancer, and reported the use of digital technology for social support. Study characteristics, population demographics, and technological interventions reported were extracted.
RESULTS In all, 15 articles from 12 studies were included in the scoping review. The results were centralized in four countries, and the most common cancer type reported was breast. Online health communities, Internet-based resources, mobile applications, and telecommunication were the four digital technologies reported. Overall, the articles demonstrated that the use of digital technology for social support can be beneficial for individuals diagnosed with cancer in LMICs.
CONCLUSION There is a limited understanding of how digital technology can be used to support individuals with cancer in LMICs. Future research is needed to explore how digital technology can be utilized by underrepresented regions to offer avenues of support for regionally common cancer types such as cervical. Fundamentally, this scoping review highlights the need for additional research on the use of digital technology to support individuals with a cancer diagnosis in LMICs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
